Everest Organics

29
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE334C01029
  • NSEID:
  • BSEID: 524790
INR
203.45
-29.2 (-12.55%)
BSENSE

Mar 30

BSE+NSE Vol: 29.81 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -19.15% vs 7.75% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -34.26% vs 1,081.61% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -5.06% vs 65.18% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -1,026.94% vs 176.40% in Mar 2024

Compare Profit and Loss Results of Everest Organics
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
182.00
386.00
-204.00
-52.85%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
22.00
0.00
22.00
0%
Net Sales
159.00
386.00
-227.00
-58.81%
Expenditure (Ex Depriciation)
Stock Adjustments
1.00
-3.00
4.00
133.33%
Raw Materials Consumed
97.00
310.00
-213.00
-68.71%
Power & Fuel Cost
14.00
2.00
12.00
600.00%
Employee Cost
16.00
8.00
8.00
100.00%
Operating Expenses
11.00
5.00
6.00
120.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
2.00
2.00
100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
0.00
1.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
152.00
382.00
-230.00
-60.21%
Operating Profit (PBDIT) excl Other Income
7.00
3.00
4.00
133.33%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
7.00
4.00
3.00
75.00%
Interest
5.00
0.00
5.00
0%
Profit before Depriciation and Tax
2.00
3.00
-1.00
-33.33%
Depreciation
5.00
2.00
3.00
150.00%
Profit Before Taxation & Exceptional Items
-3.00
1.00
-4.00
-400.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-3.00
1.00
-4.00
-400.00%
Provision for Tax
-1.00
0.00
-1.00
0%
Profit After Tax
-1.00
0.00
-1.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
34.00
-11.00
45.00
409.09%
Profit Available for appropriations
32.00
-10.00
42.00
420.00%
Appropriations
32.00
-10.00
42.00
420.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-2.97
0.115
-3.09
-2,682.61%
Profit And Loss - Net Sales
Net Sales 159.48 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -19.15% vs 7.75% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.22 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -34.26% vs 1,081.61% in Mar 2024

Profit And Loss - Interest
Interest 5.19 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -5.06% vs 65.18% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax -1.29 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -1,026.94% vs 176.40% in Mar 2024